Mary Clare Kennedy, PhD, is a Research Scientist with the BC Centre on Substance Use (BCCSU), a Public Scholar with the University of British Columbia (UBC), and a Doctoral Student in the School of Population and Public Health at UBC. Mary Clare’s research focuses on the long-term health impacts of using Insite, North America’s first supervised injection site. In her position with the BCCSU, Mary Clare coordinates a program of research investigating supervised injection services and also conducts research with the Vancouver Injection Drug Users Study and the AIDS Care Cohort to Evaluate Exposure to Survival Services cohort studies. Mary Clare has numerous publications in leading addiction, HIV/AIDS, and public health academic journals. She has received several awards during her doctoral studies, including a Faculty of Medicine Graduate Award and a Public Scholars Award, both from UBC. She is currently supported by a three-year Mitacs Accelerate Award from Mitacs Canada.